Similar articles

• On the pathogenetic role of prostaglandins in Bartter's syndrome.

  Nielsen I, Hesse B, Christensen P. Nielsen I, et al. Acta Med Scand Suppl. 1979;625:135-40. doi: 10.1111/j.0954-6820.1979.tb00758.x. Acta Med Scand Suppl. 1979. PMID: 285569
• Some aspects of urinary kallikrein in a patient with Bartter's syndrome.

  Tamura Y, Matsuda Y, Yamada K, Takagi T, Nishikawa T, Watanabe M, Mikami K, Moriya H, Kumagai A. Tamura Y, et al. Adv Exp Med Biol. 1979;120B:515-24. Adv Exp Med Biol. 1979. PMID: 517245 No abstract available.
• Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.

  Lechi A, Mantero F, Opocher G, Armanini D, Lechi C, Covi G. Lechi A, et al. J Endocrinol Invest. 1981 Jan-Mar;4(1):17-20. doi: 10.1007/BF03349408. J Endocrinol Invest. 1981. PMID: 7016967
• Prostaglandins and Bartter's syndrome.

  Dunn MJ. Dunn MJ. Kidney Int. 1981 Jan;19(1):86-102. doi: 10.1038/ki.1981.12. Kidney Int. 1981. PMID: 7012423 Review. No abstract available.
• Role of prostaglandins in the pathogenesis of Bartter's syndrome.

  Fichman MP, Telfer N, Zia P, Speckart P, Golub M, Rude R. Fichman MP, et al. Am J Med. 1976 May 31;60(6):785-97. doi: 10.1016/0002-9343(76)90892-5. Am J Med. 1976. PMID: 798488 Review.